Submit a Release
Home
All
ESG
Health
Technology
Finance
Contributors
Sub Menu
Submit a Release
main-search-pop
Main menu
Health
Results: 3649-3660 of 4018
Waters Accelerates Oligonucleotide Bioanalysis with the Launch of OligoWorks™ SPE Workflow and Kits
Qilu Pharmaceutical to Showcase Novel Anti-Cancer Drug QL1706 at ESMO Congress 2023
4Moving Biotech Completes the Recruitment of Its Phase I Clinical Trial in Patients With Knee Osteoarthritis
TASO launches new online resource for universities to support student mental health
Virology Education Presents the Demystifying Long COVID-19 International Conference 2023 7-9 December 2023
Daewoong Pharmaceutical to Participates in CPHI Worldwide 2023, Showcasing Own Novel Drug in the Global Market
Protembis Announces FDA Approval of its Pivotal Investigational Device Exemption (IDE) Study
ProstACT SELECT Study of TLX591 Interim Readout: Positive Results Confirm Safety and Tolerability
European Commission Approves ADCETRIS® (brentuximab vedotin) for the Treatment of Adult Patients with Previously Untreated CD30+ Stage III Hodgkin Lymphoma in Combination with AVD
Alkermes to Report Third Quarter Financial Results on October 25, 2023
Inside information: Bioretec estimates that the approval of the European market authorization for the biodegradable RemeOs™ trauma screw will move to the first quarter of 2024
TaCa Healthcare is Revolutionizing the Healthcare Industry by Making Elective Secondary Care Surgeries More Affordable and Accessible.
Prev
Page
1
2
…
304
305
306
…
334
335
Next
Page
